Pathogenic/likely pathogenic variants in SMAD4 (encoding the transcription factor Smad4) have been described in less than 2% of the HHT population associated with juvenile polyposis/HHT overlap syndrome [8]. This evidence concerns the gene SMAD4 and juvenile polyposis syndrome.